Improving Attention in Individuals With Long COVID-19

Description

This study is to find out if the Attention Processing Training program is a potential treatment for brain fog symptoms, reported by people with Long-Covid. Also investigating the feasibility of completing this program virtually.

Conditions

Long Covid

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is to find out if the Attention Processing Training program is a potential treatment for brain fog symptoms, reported by people with Long-Covid. Also investigating the feasibility of completing this program virtually.

Intensive Attention Training to Treat Brain Fog in Individuals With Long-Covid

Improving Attention in Individuals With Long COVID-19

Condition
Long Covid
Intervention / Treatment

-

Contacts and Locations

Chicago

Shirley Ryan AbilityLab, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Aged 18-65 years. Live in the Chicagoland area
  • * A history of confirmed SARS-CoV-2 infection.
  • * Subjective reports of cognitive symptoms that interfere with everyday activities, starting on or shortly after SARS-CoV-2 infection.
  • * Continuation or development of Long-Covid brain fog 3 months after the initial SARS-CoV-2 infection, with these symptoms lasting for at least 2 months with no other explanation.
  • * Objective attentional deficits as measured by the Conners CPT-312, and/or the Digit Span subtest (WAIS- III13).
  • * Able to use a keyboard.
  • * Able to understand and communicate in English.
  • * Able to consent independently.
  • * Being hospitalized due to COVID-19 diagnosis for more than 3 days.
  • * Pre-morbid neurological conditions that could potentially affect cognition, such as Parkinson's Disease, Alzheimer's Dementia, acquired brain injury.
  • * Severe depression.
  • * Currently enrolled in cognitive training or physical exercise training.
  • * Receiving chemotherapy or radiation within last 6 months.
  • * Active substance abuse.

Ages Eligible for Study

18 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Shirley Ryan AbilityLab,

Shira Cohen-Zimerman, PhD, PRINCIPAL_INVESTIGATOR, Shirley Ryan AbilityLab

Elliot Roth, MD, PRINCIPAL_INVESTIGATOR, Shirley Ryan AbilityLab

Study Record Dates

2027-03-01